Cara Therapeutics - Multiplikator EV/Sales TVRD

Simbol resmi perusahaan Cara Therapeutics, Inc. (TVRD)

The enterprise value assessment via EV/Sales demonstrates the business model of Cara Therapeutics Inc (TVRD), which relies on external outsourcing for development and trials. The stability of this strategy is supported by strict control over biopharmaceutical supply chains and long-term SLAs with sterile injectable manufacturers. The value 0.00 represents the current metric, capturing market expectations for the company's revenue.

Cara Pharma - Multiplikator EV/Sales TVRD (periode 23.11.2025 - 21.11.2026)

Rincian metrik keuangan lan pasar Cara Therapeutics (TVRD)

Pambiji fundamental perusahaan:Cara Therapeutics Inc TVRD
Sampel barang caratherapeutics.com

Professional asset selection begins with an analysis of capitalization efficiency relative to operating income. This indicator aggregates market value and net debt, comparing the total against annual turnover. By analyzing the current enterprise value-to-revenue ratio, an investor determines the extent of the business premium. The stability of this ratio for Cara Therapeutics Inc (TVRD) is supported by a robust biopharmaceutical logistics system. Strict control of supply temperature regimes ensures drug integrity and the commercial stability of the company.